Hepatocyte Growth Factor is a heparin binding protein that stimulates proliferation, migration and morphological differentiation of a variety of cellular targets. This signaling is important for normal development of liver, placenta, neural development, and contributes to cytoprotection and repair in the kidney, liver and lung tissues. Our interest has focused on the Hepatocyte Growth Factor and its interaction with MET. Heparin binding to Hepatocyte Growth Factor has been implicated in ligand-induced dimerization of the Met receptor. Mutations were made in the N-terminal domain of Hepatocyte Growth Factor based on contacts in dimeric crystal structures in an attempt to inhibit dimerization and engineer antagonists.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC011130-01
Application #
7733521
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2008
Total Cost
$66,265
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code